Noscendo

Noscendo GmbH, a molecular diagnostics company located in Duisburg, Germany, is transforming the identification of infectious pathogens. By utilizing patented algorithms and software to enable a paradigm shift, Noscendo introduces the concept of liquid biopsy to the field of infectious diseases through next-generation sequencing of cell-free nucleic acids isolated from patient samples.Noscendo's software solution can differentiate between infectious and non-infectious signals, assisting intensive care physicians in making the right decisions in their daily practice, thereby enabling targeted and successful treatment within a feasible timeframe.